A retrospective study to explore the efficacy and safety of FOLFOX therapy and FOLFOX with radiation in esophageal squamous cell carcinoma
Not Applicable
- Conditions
- esophageal squamous cell carcinoma
- Registration Number
- JPRN-UMIN000047501
- Lead Sponsor
- ational Hospital Organization Nagoya Medical Center, Department of Medical Oncology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 143
Inclusion Criteria
Not provided
Exclusion Criteria
Duplicate cancers (simultaneous duplicate cancers and iatrogenic duplicate cancers with a disease-free interval of 3 years or less). However, patients with overlapping cancers that are not prognostic factors are not excluded. Patients with cardiovascular complications that are not stabilized by pharmacological therapy alone.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method